BioCrossroads Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 75

  • Portfolio
  • 28

  • Exits
  • 25

Exits

BioCrossroads General Information

Company Description

Founded in 2002, BioCrossroads is a venture capital investment firm based in Indianapolis, Indiana. The firm prefers investing in the biotechnology, pharmaceutical, medical device, diagnostic, ag-tech, biotech, and health information technology sectors.

Business Details

Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 1210 Waterway Boulevard
  • Suite 5000
  • Indianapolis, IN 46202
  • United States
+1 (317) 000-0000

BioCrossroads Investments (75)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Gate Neurosciences 05-Oct-2022 Early Stage VC 0000 Other Healthcare Services Pre-Clinical Trials
Sabanto 01-Jul-2022 00000 00000 0000 Machinery (B2B) Generating Revenue
Novosteo 29-Dec-2021 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 0000 0000000
Lumavate 01-Dec-2021 00000 00000 000 Software Development Applications Generating Revenue
Scioto Biosciences 12-Nov-2021 00000 00000 00.00 Drug Delivery Clinical Trials - Phase 2
Kovina Therapeutics 29-Jun-2021 0000 00000 000 Biotechnology Pre-Clinical Trials
Gate Neurosciences 29-Mar-2021 0000 00000 00.00 Other Healthcare Services Pre-Clinical Trials 0000 0000000
Scioto Biosciences 10-Aug-2020 00000 00000 000 Drug Delivery Clinical Trials - Phase 2
MBX Biosciences 27-Jul-2020 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 0000 0000000
Fresh Tracks Therapeutics 22-Jun-2020 Public Investment 2nd Offering 000.00 Drug Delivery Generating Revenue/Not Profitable 0000 0000000
You’re viewing 10 of 75 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCrossroads Exits (25)

Company Name Exit Date Exit Type Exit Size
Backline by DrFirst 01-Feb-2023 Merger/Acquisition
Jace Medical 01-Feb-2023 000000000000000000 00000
Novosteo 19-May-2022 000000000000000000 000.00
Sexton Biotechnologies 01-Sep-2021 000000000000000000 000.00
Sintact Medical Systems 30-Apr-2021 000 00 00000000
Grest 01-Jan-2021 000000000 00000000
SonarMed 31-Dec-2020 000000000000000000
FlowCo (Diagnostic Equipment) 30-Dec-2020 000000000 00000000
Inscope Medical Solutions 01-Nov-2020 Merger/Acquisition
Fresh Tracks Therapeutics 23-Oct-2020 Public Investment 2nd Offering 0000
You’re viewing 10 of 25 exits. Get the full list »

BioCrossroads Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BioCrossroads Management, Team & Partners (11)

Name Title Deals Funds Boards Office
Vince Wong Chief Executive Officer & President Indianapolis, IN
Jane Dunigan-Smith Senior Vice President, Chief Strategy Officer & Managing Director of Seed Funds 0 0 Indianapolis, IN
Mike Bolinder Chief Innovation Officer & Senior Vice President Indianapolis, IN
Darshan Shah Senior Vice President & Chief Data Officer Indianapolis, IN
You’re viewing 4 of 11 team members. Get the full list »

BioCrossroads Co-Investors (29)

Name With Exits Lead Partner Series Industry
Elevate Ventures 3 0 0 Series chart Industry bar
IU Ventures 0 0 Series chart Industry bar
Frazier Healthcare Partners 0 0 Series chart Industry bar
New Enterprise Associates 0 0 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
You’re viewing 5 of 29 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »